Results 221 to 230 of about 2,562,087 (294)

Weight Regain After Incretin Treatment: The Lean Mass Deficit Hypothesis and a Role for Testosterone Combination Therapy in Men

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs), dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1RA and triple (GIP)/GLP‐1RA/glucagon agonists achieve placebo‐subtracted weight loss of 15% to 22%. Their long‐term value depends on how well the weight loss is maintained and on the composition of weight loss, not only
Michael Zitzmann   +3 more
wiley   +1 more source

Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation. [PDF]

open access: yesMater Today Bio
Zheng H   +9 more
europepmc   +1 more source

Long‐term outcomes and repeat percutaneous cryoablation in hereditary RCC: a EuRECA cohort

open access: yes
BJU International, EarlyView.
Jens Borgbjerg   +16 more
wiley   +1 more source

CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems

open access: yesThe FEBS Journal, EarlyView.
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén   +11 more
wiley   +1 more source

Respiratory Syncytial Virus-Associated Disease in Children Receiving Intensive Care.

open access: yesJAMA Netw Open
Olson TL   +4 more
europepmc   +1 more source

IgE-mediated food allergy and upper urinary tract disorders in children: A matched study. [PDF]

open access: yesPediatr Allergy Immunol
Magen E   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy